TrialPanorama/TrialPanorama-database huggingface dataset:
Study 38986210 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 38986212 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38986421 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38986421 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 38986608 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38986891 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 38987228 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 38987318 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 38987318 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 38987318 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 38987421 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 38987671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38987721 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 38988185 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 38988743 — Safety Biomarker (SAF): Interleukin 1
Study 38989414 — Safety Biomarker (SAF): Interleukin 12
Study 38990090 — Predictive Biomarker (PRD): Microsatellite instability
Study 38990433 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 38990433 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 38990927 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 38991123 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 38991123 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 38991137 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38991216 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 38991582 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 38991672 — Surrogate Endpoint (SUR): Blood pressure
Study 38991671 — Surrogate Endpoint (SUR): Blood pressure
Study 38991714 — Surrogate Endpoint (SUR): Blood pressure
Study 38992025 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38992025 — Predictive Biomarker (PRD): KCNAB1 mRNA
Genes: KCNAB1; KCNA1B
Study 38992025 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 38992123 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 38992129 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 38993150 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38993854 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 38994536 — Surrogate Endpoint (SUR): Serum sodium
Study 38994833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38995194 — Surrogate Endpoint (SUR): Blood pressure
Study 38995311 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 38995311 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 38995690 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38996463 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 38996463 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38996463 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38996519 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 38997435 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 38997620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38997620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38997620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38997620 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 38997668 — Surrogate Endpoint (SUR): Blood pressure
Study 38997676 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 39001736 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 39001736 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39002122 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 39003182 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 39003182 — Surrogate Endpoint (SUR): Pathological complete response
Study 39003185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39003185 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 39003185 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39003306 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 39003306 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 39003347 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 39003487 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 39003487 — Surrogate Endpoint (SUR): Bone mineral density
Study 39003487 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 39004217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39004647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39005691 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39006439 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 39006439 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39007062 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 39007066 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 39007836 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 39007915 — Predictive Biomarker (PRD): KLF10 mRNA
Genes: KLF10; TIEG; TIEG1
Study 39007942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39007997 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 39008067 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 39008317 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 39008481 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 39008481 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39008826 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 39008858 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 39008999 — Surrogate Endpoint (SUR): Bone mineral density
Study 39009040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39009040 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 39009116 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39009804 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 39010232 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 39010708 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 39010708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39011963 — Surrogate Endpoint (SUR): Blood pressure
Study 39012221 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39012233 — Safety Biomarker (SAF): Hyaluronic acid
Study 39012250 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 39012630 — Surrogate Endpoint (SUR): Blood pressure
Study 39012717 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 39012717 — Predictive Biomarker (PRD): COL1A2 mRNA
Genes: COL1A2
Study 39012717 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39012717 — Surrogate Endpoint (SUR): Bone mineral density
Study 39012843 — Safety Biomarker (SAF): IL-6 and IL-10
Study 39012946 — Surrogate Endpoint (SUR): Blood pressure
Study 39013470 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39013654 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 39013870 — Surrogate Endpoint (SUR): Pathological complete response
Study 39014136 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39014463 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 39014551 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 39015176 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 39015189 — Predictive Biomarker (PRD): F2R mRNA
Genes: F2R; CF2R; PAR1; TR
Study 39015350 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39016010 — Surrogate Endpoint (SUR): Blood pressure
Study 39016053 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39016381 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 39017806 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 39018038 — Predictive Biomarker (PRD): IL13RA1 mRNA
Genes: IL13RA1; IL13R; IL13RA
Study 39018053 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39018053 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39018053 — Predictive Biomarker (PRD): Hormone receptor
Study 39018531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39019119 — Predictive Biomarker (PRD): IGFBP4 mRNA
Genes: IGFBP4; IBP4
Study 39019119 — Surrogate Endpoint (SUR): Bone mineral density
Study 39019119 — Safety Biomarker (SAF): Vitamin K-dependent protein S
Genes: PROS1; PROS
Study 39019150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 39019496 — Surrogate Endpoint (SUR): Blood pressure
Study 39019657 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39019875 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 39019979 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study 39019979 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study 39019979 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A2 mRNA
Genes: SRD5A2
Study 39020305 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 39020446 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 39020503 — Surrogate Endpoint (SUR): Probing pocket depth
Study 39020518 — Surrogate Endpoint (SUR): Pathological complete response
Study 39021216 — Surrogate Endpoint (SUR): Serum creatinine
Study 39022168 — Safety Biomarker (SAF): Interleukin 1
Study 39022429 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 39022796 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39022889 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 39023142 — Surrogate Endpoint (SUR): Blood pressure
Study 39023253 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39023253 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39023287 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study 39023418 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 39023418 — Surrogate Endpoint (SUR): Blood pressure
Study 39023568 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study 39023568 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39023568 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 39023568 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 39023568 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 39023568 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 39023880 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 39024777 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39025066 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 39025092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39025264 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 39025264 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 39025948 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39025948 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 39025948 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 39025948 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39026154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39026154 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 39026154 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 39026154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39026552 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 39027419 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 39027664 — Surrogate Endpoint (SUR): Blood pressure
Study 39028412 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study 39028763 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39028916 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39028916 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 39028923 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39028931 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39028931 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 39029241 — Surrogate Endpoint (SUR): Pathological complete response
Study 39029295 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 39029568 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39029876 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39029876 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 39030063 — Surrogate Endpoint (SUR): Blood pressure
Study 39030183 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 39030183 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 39031189 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 39031276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39031276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39031356 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 39031356 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 39031356 — Safety Biomarker (SAF): BDNF
Study 39031356 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 39033240 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 39033369 — Surrogate Endpoint (SUR): Blood pressure
Study 39033692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 39033692 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39033767 — Predictive Biomarker (PRD): Chromosome 5q
Study 39033770 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 39033774 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 39033774 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 39033774 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study 39033924 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 39033994 — Surrogate Endpoint (SUR): Blood pressure
Study 39034414 — Surrogate Endpoint (SUR): Blood pressure
Study 39034493 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 39035044 — Predictive Biomarker (PRD): NEO1 mRNA
Genes: NEO1; IGDCC2; NGN
Study 39035044 — Surrogate Endpoint (SUR): Forced vital capacity
Study 39035614 — Surrogate Endpoint (SUR): Blood pressure
Study 39035725 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 39035774 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39036069 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39037824 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 39037964 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39037964 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 39037964 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 39037964 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39038251 — Predictive Biomarker (PRD): KLK2 mRNA
Genes: KLK2
Study 39038251 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 39038404 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 39038917 — Predictive Biomarker (PRD): MAGEA1 mRNA
Genes: MAGEA1; MAGE1; MAGE1A
Study 39038917 — Safety Biomarker (SAF): Human leucocyte antigen
Study 39039086 — Predictive Biomarker (PRD): JUN mRNA
Genes: JUN
Study 39039086 — Predictive Biomarker (PRD): ZAP70 mRNA
Genes: ZAP70; SRK
Study 39039086 — Predictive Biomarker (PRD): EPHB2 mRNA
Genes: EPHB2; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5
Study 39039449 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 39039509 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 39039516 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 39039609 — Surrogate Endpoint (SUR): Blood pressure
Study 39041200 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 39041200 — Predictive Biomarker (PRD): Microsatellite instability
Study 39041351 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 39041351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 39041411 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 39042017 — Safety Biomarker (SAF): Hyaluronic acid
Study 39042292 — Surrogate Endpoint (SUR): Bone mineral density
Study 39042613 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 39042613 — Predictive Biomarker (PRD): NFKBIA mRNA
Genes: NFKBIA; IKBA; MAD3; NFKBI
Study 39042613 — Predictive Biomarker (PRD): NFKBIZ mRNA
Genes: NFKBIZ; IKBZ; INAP; MAIL
Study 39042613 — Predictive Biomarker (PRD): FOSL2 mRNA
Genes: FOSL2; FRA2
Study 39042613 — Predictive Biomarker (PRD): JDP2 mRNA
Genes: JDP2
Study 39042613 — Predictive Biomarker (PRD): PIK3R1 mRNA
Genes: PIK3R1; GRB1
Study 39042613 — Predictive Biomarker (PRD): CLEC7A mRNA
Genes: CLEC7A; BGR; CLECSF12; DECTIN1; UNQ539/PRO1082
Study 39042613 — Predictive Biomarker (PRD): DUSP6 mRNA
Genes: DUSP6; MKP3; PYST1
Study 39042613 — Predictive Biomarker (PRD): NCF2 mRNA
Genes: NCF2; NOXA2; P67PHOX
Study 39042613 — Predictive Biomarker (PRD): PLCB1 mRNA
Genes: PLCB1; KIAA0581
Study 39042770 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 39042892 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 39043009 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39043348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39043397 — Surrogate Endpoint (SUR): Blood pressure
Study 39043682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39043682 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 39043682 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 39043871 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 39043915 — Surrogate Endpoint (SUR): Bone mineral density
Study 39044019 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 39044659 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 39044797 — Safety Biomarker (SAF): Interleukin 1
Study 39044861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 39045200 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39045484 — Surrogate Endpoint (SUR): Blood pressure
Study 39045544 — Surrogate Endpoint (SUR): Pathological complete response
Study 39045758 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 39045758 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 39045758 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 39046150 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 39046616 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 39046616 — Predictive Biomarker (PRD): GP2 mRNA
Genes: GP2
Study 39046616 — Predictive Biomarker (PRD): Hormone receptor
Study 39046647 — Predictive Biomarker (PRD): ADCY10 mRNA
Genes: ADCY10; SAC
Study 39046695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 39046695 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 39046727 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 39046727 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 39046783 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2